of the Protocol outlines provisions regarding exemptions from the advance informed agreement procedure as it applies to living modified organisms that are in transit
and those that are destined for contained use
Living Modified Organisms in Transit
Article 6, paragraph 1, of the Protocol provides that, notwithstanding the scope of the Protocol and without prejudice to any right of a Party of transit to regulate the transport of living modified organisms through its territory and make available to the Biosafety Clearing-House, any decision of that Party, subject to Article 2
, paragraph 3, regarding the transit through its territory of a specific living modified organism, the provisions of the Protocol with respect to the advance informed agreement procedure shall not apply to the transboundary movement of living modified organisms in transit.
History of COP-MOP Decisions on Transit
Discussions on the rights and obligations of transit States were first taken up by the COP-MOP in their second and third meetings. At their second meeting the Parties considered a way forward based on information submitted by Parties, other Governments and relevant organisations. In their decision BS-II/14
, the COP-MOP invited Parties, other Governments and relevant international organizations to submit additional views clarifying the rights and/or obligations of transit States, particularly related to documentation, for consideration by the third meeting of the COP-MOP.
In considering the views submitted by the Parties, in their decision BS-III/16
, the COP-MOP further invited Parties, other Governments and relevant international organizations to provide views and information on experience on the rights and/or obligations of Parties of transit of living modified organisms, for consideration at its fifth meeting.
At their fifth meeting, in decision BS-V/10
, Parties took note of the views expressed and the discussions held in relation to the rights and/or obligations of Parties of transit of living modified organisms at its second and third meetings and considered the absence of new submissions of views or information from Parties to the Protocol on this item and decided to consider this item at its eighth meeting while encouraging Parties to continue addressing issues related to the transit of living modified organisms through their territories using their domestic administrative and legal systems.
Furthermore the Parties reiterated the need to review the status of implementation of the provisions of the Protocol or any decision by Parties related to the transit of living modified organisms with the adoption of decision BS-V/16
outlining the programme of work for the Cartagena Protocol for the period 2012-2016 as well as the Strategic Plan
for implementation of the Protocol for the period 2011-2020 in which Operational Objective 1.8
highlights as a priority the outcome of enabling Parties to manage LMOs in transit.
Living Modified Organisms Destined for Contained Use
For the purposes of the Protocol, Article 3
(b) states that “‘use’ means any operation, undertaken within a facility, installation or other physical structure, which involves living modified organisms that are controlled by specific measures that effectively limit their contact with, and their impact on, the external environment”.
Article 6, paragraph 2, of the Protocol further provides that, notwithstanding the scope of the Protocol and without prejudice to any right of a Party to subject all living modified organisms to risk assessment prior to decisions on import and to set standards for contained use within its jurisdiction, the provisions of the Protocol with respect to the advance informed agreement procedure shall not apply to the transboundary movement of living modified organisms destined for contained use undertaken in accordance with the standards of the Party of import.
History of COP-MOP Decisions on Contained Use
In its decision BS-V/16
the COP-MOP adopted a programme of work for the Cartagena Protocol for the period 2012-2016. In its decision the Parties decided to consider, at their seventh meeting, the contained use of living modified organisms and the development of tools and guidance that facilitate the implementation of the Protocol's provisions on contained use of LMOs.
In that same decision, with the adoption of the Strategic Plan
for implementation of the Protocol for the period 2011-2020 by the COP-MOP, contained use of living modified organisms was addressed under Operational Objective 1.8
with the view to facilitating Parties having in place measures for contained use.
At their seventh meeting the COP-MOP took up the item on contained use and, in their decision BS-VII/4
, invited Parties and other Governments to submit to the Executive Secretary information, tools, practical experience and guidance related to their existing mechanisms and requirements relating to the contained use of living modified organisms, including any specific requirement relating to the type and level of containment. The Parties decided to consider, at its eighth meeting, the gaps and needs identified by Parties, if any, with a view to facilitating the implementation of the Protocol’s provisions on contained use of living modified organisms, taking into account the information provided through their submissions.